Glasgow Biomedicine
Glasgow Clinical Trials Unit (GCTU)
The GCTU was established to support all aspects of clinical trial research for Glasgow Biomedicine; from concept and clinical trial design, data management and monitoring, through to analysis and reporting. The GCTU is accredited by the UK Clinical Research Network (UKCRN) and supports both academic and commercial studies.
Established within the University of Glasgow and NHS GG&C, the GCTU provides specialist services from the Glasgow Clinical Research Facility, the Robertson Centre for Biostatistics, and the NHS GG&C R & D department.
Glasgow Clinical Research Facility (GCRF)
Significant capital investment and refurbishment provides an integrated hub of two floors of research space in the GCRF, including a clinical research floor in the adjacent BHF Glasgow Cardiovascular Research Centre. Proximity to the new state-of-the-art biomedical research buildings, fosters translational research studies that address key national health priorities and covers trials in all areas of medicine.
With common IT approaches and web-based systems, the GCRF, as a key part of a network of clinical research centres in Scotland, plays a significant role in helping to support the large-scale population-based studies such as:
- UK Biobank
- Scottish Genetic Healthcare Initiative.
The GCRF is integrated closely with other clinical research developments, reflecting the importance of the joint strategic objectives of the University and NHS GG&C to ensure delivery on clinical research in Glasgow. Training and mentoring forms a critical component. This ensures long-term development and growth, making the GCRF a focus of excellence in clinical research in the West of Scotland for clinical scientists and other health professionals. Also a key component of the GCRF, is the cadre of full-time nurses working to defined protocols and trained in state-of-the-art research techniques.

Robertson Centre for Biostatistics
The Robertson Centre for Biostatistics forms a key part of Glasgow Biomedicine and has an international reputation for its work in clinical trials, epidemiology and health economics. It played a major role in significant clinical trials such as WOSCOPS (West of Scotland Coronary Prevention Study) and PROSPER (Prospective Study of Pravastatin in the Elderly at Risk).
